The global market place for tailored medication is poised to achieve $3.18 trillion over the coming half-decade. While cellular and genetic therapy paradigms offer myriad benefits for biotech enterprises and their clientele, realizing treatments for patients presents numerous hurdles. Luckily, the emergence and progression of artificial intelligence arrive opportunistically to aid life sciences...

The global cancer gene therapy market size is expected to reach USD 12.76 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to register a CAGR of 18.9% from 2024 to 2030 owing to the increasing demand for novel therapeutics globally and rising incidence of cancer cases globally. Moreover, this therapy offers an absolute solution to...

Executive Summary Europe Gene Therapy Market : Data Bridge Market Research analyzes that the Europe gene therapy market is expected to reach USD  7,422.28 million by 2030, at a CAGR of 17.6% during the forecast period.  The market report also provides the drivers and restraints for the Europe Gene Therapy Market that are obtained with the help of SWOT analysis, and also...

The global gene therapy market is expected to reach USD 18.20 billion by 2030, registering a CAGR of 18.88% from 2024 to 2030, according to a new report by Grand View Research, Inc. The development of the market is owing to an increase in the number of gene therapy-based discoveries, increasing investment in this sector, and rising approval of gene therapy products. According to the...

What This Report Offers: Detailed Hemophilia Gene Therapy Market Breakdown — Clear segmentation by type, application, and key regions so you know exactly where the opportunities lie. Actionable Strategic Insights — Concrete recommendations to help you strengthen your competitive edge and accelerate business growth. Comprehensive Hemophilia Gene Therapy Market Outlook...